Figure 9.
Risk score correlated with clinicopathological features in bladder cancer. (A) The heatmap revealed the difference in clinical characteristics between the high- and low-risk groups in bladder cancer. (B–G) The risk score in different tumor grades (B), clinical stages (C), pT stages (D), pN stages (E), ImmuneScore (F), and clusters (G) of bladder cancer patients. *P < .05, **P < .01, and ***P < .001.